Insider Trading & Ownership - Seehra Jasbir

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Seehra Jasbir
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-04-13
Purchase
2020-04-13
5:19 pm
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
20,000$16$320,000243,856
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-23
Option Award
2024-02-23
5:07 pm
N/A
2034-02-22
Keros Therapeutics Inc.KROSSeehra Jasbir
CHIEF EXECUTIVE OFFICER
125,000$0125,000
(Direct)
View
2024-02-13
Option Award
2024-02-15
8:41 pm
N/A
2034-02-12
Keros Therapeutics Inc.KROSSeehra Jasbir
CHIEF EXECUTIVE OFFICER
125,000$0125,000
(Direct)
View
2023-04-08
Exercise
2023-04-11
4:05 pm
N/A
2029-06-18
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
4,000$0297,943
(Direct)
View
2023-04-08
Exercise
2023-04-11
4:05 pm
N/A
N/A
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
4,000$0.48297,943
(Direct)
View
2023-02-16
Option Award
2023-02-17
4:13 pm
N/A
2033-02-15
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
200,000$0200,000
(Direct)
View
2022-06-15
Option Award
2022-06-17
08:28 am
N/A
2032-06-15
Eloxx Pharmaceuticals Inc.ELOXSeehra Jasbir
Director
20,000$020,000
(Direct)
View
2022-06-09
Exercise
2022-06-10
4:12 pm
N/A
N/A
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
5,000$0.3257,678
(Direct)
View
2022-06-09
Exercise
2022-06-10
4:12 pm
N/A
2028-03-25
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
5,000$0257,678
(Direct)
View
2022-01-21
Option Award
2022-01-25
4:17 pm
N/A
2032-01-20
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
165,000$0165,000
(Direct)
View
2021-05-19
Option Award
2021-05-20
4:10 pm
N/A
2031-05-19
Eloxx Pharmaceuticals Inc.ELOXSeehra Jasbir
Director
20,000$020,000
(Direct)
View
2021-01-10
Option Award
2021-01-12
5:20 pm
N/A
2031-01-09
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
127,200$0127,200
(Direct)
View
2020-05-20
Option Award
2020-05-22
4:10 pm
N/A
2030-05-20
Eloxx Pharmaceuticals Inc.ELOXSeehra Jasbir
Director
20,000$020,000
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:19 pm
N/A
N/A
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
11,169$0243,856
(Direct)
View
2020-04-07
Option Award
2020-04-08
9:03 pm
N/A
2030-04-06
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
696,569$0696,569
(Direct)
View

Ownership
2020-04-07
7:39 pm
N/A
N/A
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
0$0588,576
(Direct)
View
2019-05-29
Option Award
2019-05-29
5:10 pm
N/A
2029-05-29
Eloxx Pharmaceuticals Inc.ELOXSeehra Jasbir
Director
20,000$020,000
(Direct)
View